Allergy Therapeutics plc
AGY.L · LSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £12,790 | £12,915 | £14,845 | £20,515 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £7,972 | £7,823 | £7,088 | £10,468 |
| Inventory | £13,915 | £12,744 | £11,593 | £11,410 |
| Other Curr. Assets | £0 | £0 | £0 | £0 |
| Total Curr. Assets | £34,677 | £33,482 | £33,526 | £42,393 |
| Property Plant & Equip (Net) | £24,258 | £23,745 | £23,241 | £20,190 |
| Goodwill | £3,325 | £3,317 | £3,346 | £3,347 |
| Intangibles | £931 | £1,370 | £4,400 | £5,035 |
| Long-Term Investments | £0 | £0 | £0 | £0 |
| Tax Assets | £1,513 | £0 | £0 | £0 |
| Other NC Assets | £2,839 | £2,913 | £2,256 | £1,983 |
| Total NC Assets | £32,866 | £31,345 | £33,243 | £30,555 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £67,543 | £64,827 | £66,769 | £72,948 |
| Liabilities | – | – | – | – |
| Payables | £4,491 | £4,015 | £4,090 | £4,282 |
| Short-Term Debt | £1,880 | £2,116 | £1,803 | £2,268 |
| Tax Payable | £1,427 | £4,734 | £4,443 | £4,267 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £19,394 | £9,680 | £8,229 | £7,236 |
| Total Curr. Liab. | £27,192 | £20,545 | £18,565 | £18,053 |
| LT Debt | £58,209 | £28,872 | £34,186 | £8,261 |
| Deferred Rev, NC | £0 | £0 | £7,747 | £6,764 |
| Deferred Tax Liab, NC | £68 | £382 | £454 | £406 |
| Other NC Liab. | £10,267 | £11,319 | £11,498 | £8,463 |
| Total NC Liab. | £68,544 | £40,573 | £46,138 | £17,130 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £6,644 | £7,888 | £8,902 | £8,080 |
| Total Liabilities | £95,736 | £61,118 | £64,703 | £35,183 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £812 | £0 |
| Common Stock | £4,766 | £4,776 | £679 | £654 |
| Retained Earnings | -£195,098 | -£198,927 | -£121,742 | -£78,414 |
| AOCI | £7,500 | £1,311 | £2,588 | £2,949 |
| Other Equity | £154,649 | £196,549 | £119,030 | £112,576 |
| Total Equity | -£28,193 | £3,709 | £2,066 | £37,765 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £67,543 | £64,827 | £66,769 | £72,948 |
| Net Debt | £47,299 | £18,073 | £21,144 | -£9,986 |